Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial.

Janowiak P, Krajnik M, Podolec Z, Bandurski T, Damps-Konstańska I, Sobański P, Currow DC, Jassem E.

BMC Pulm Med. 2017 Dec 11;17(1):186. doi: 10.1186/s12890-017-0535-y.

2.

Interleukin 1β polymorphism and serum level are associated with pediatric asthma.

Sobkowiak P, Wojsyk-Banaszak I, Kowalewska M, Wasilewska E, Langwiński W, Kycler Z, Skibińska M, Bręborowicz A, Jassem E, Szczepankiewicz A.

Pediatr Pulmonol. 2017 Dec;52(12):1565-1571. doi: 10.1002/ppul.23893. Epub 2017 Oct 16.

PMID:
29034996
3.

Unusual diagnosis hidden by poorly controlled asthma.

Harcęko-Zielińska E, Kuziemski K, Damps-Konstańska I, Tokarska B, Jassem E.

Kardiol Pol. 2017;75(8):816. doi: 10.5603/KP.2017.0159. No abstract available.

4.

Impact of Integrated Care Model (ICM) on Direct Medical Costs in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD).

Bandurska E, Damps-Konstańska I, Popowski P, Jędrzejczyk T, Janowiak P, Świętnicka K, Zarzeczna-Baran M, Jassem E.

Med Sci Monit. 2017 Jun 12;23:2850-2862.

5.

Recurrent haemoptysis as a symptom of severe pulmonary vein stenosis-a rare complication of catheter ablation in atrial fibrillation.

Romantowski J, Kuziemski K, Janowicz A, Siemińska A, Szurowska E, Jassem E.

Respirol Case Rep. 2017 Jan 9;5(2):e00212. doi: 10.1002/rcr2.212. eCollection 2017 Mar.

6.

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.

Lortholary O, Chandesris MO, Bulai Livideanu C, Paul C, Guillet G, Jassem E, Niedoszytko M, Barete S, Verstovsek S, Grattan C, Damaj G, Canioni D, Fraitag S, Lhermitte L, Georgin Lavialle S, Frenzel L, Afrin LB, Hanssens K, Agopian J, Gaillard R, Kinet JP, Auclair C, Mansfield C, Moussy A, Dubreuil P, Hermine O.

Lancet. 2017 Feb 11;389(10069):612-620. doi: 10.1016/S0140-6736(16)31403-9. Epub 2017 Jan 7.

PMID:
28069279
7.

The Role of TRAF4 and B3GAT1 Gene Expression in the Food Hypersensitivity and Insect Venom Allergy in Mastocytosis.

Górska A, Gruchała-Niedoszytko M, Niedoszytko M, Maciejewska A, Chełmińska M, Skrzypski M, Wasąg B, Kaczkan M, Lange M, Nedoszytko B, Pawłowski R, Małgorzewicz S, Jassem E.

Arch Immunol Ther Exp (Warsz). 2016 Dec;64(6):497-503. Epub 2016 Apr 16.

8.

Walls and Barriers. Polish Achievements and the Challenges of Transformation: Building a Hospice Movement in Poland.

Krakowiak P, Skrzypińska K, Damps-Konstańska I, Jassem E.

J Pain Symptom Manage. 2016 Oct;52(4):600-604. doi: 10.1016/j.jpainsymman.2016.07.009. Epub 2016 Aug 12. Review.

PMID:
27524404
9.

Changes in the Expression of MicroRNA in the Buildup Phase of Wasp Venom Immunotherapy: A Pilot Study.

Specjalski K, Maciejewska A, Pawłowski R, Chełmińska M, Jassem E.

Int Arch Allergy Immunol. 2016;170(2):97-100. doi: 10.1159/000447637. Epub 2016 Jul 22.

10.

Acceptance of home support and integrated care among advanced COPD patients who live outside large medical centers.

Damps-Konstańska I, Werachowska L, Krakowiak P, Kaczmarek M, Cynowska B, Górecka D, Krajnik M, Kozielski J, Jassem E.

Appl Nurs Res. 2016 Aug;31:60-4. doi: 10.1016/j.apnr.2015.12.003. Epub 2015 Dec 21.

PMID:
27397820
11.

Differentiating of cross-reactions in patients with latex allergy with the use of ISAC test.

Chełmińska M, Specjalski K, Różyło A, Kołakowska A, Jassem E.

Postepy Dermatol Alergol. 2016 Apr;33(2):120-7. doi: 10.5114/ada.2016.59154. Epub 2016 May 16.

13.

Typing safe antibiotics in amoxicillin hypersensitive patients--development of a stepwise protocol.

Specjalski K, Kita-Milczarska K, Chełmińska M, Jassem E.

Pneumonol Alergol Pol. 2016;84(1):16-21. doi: 10.5603/PiAP.2016.0001.

14.

In Vitro Evaluation of the Allergic Potential of Antibacterial Peptides: Camel and Citropin.

Pikuła M, Zieliński M, Specjalski K, Barańska-Rybak W, Dawgul M, Langa P, Jassem E, Kamysz W, Trzonkowski P.

Chem Biol Drug Des. 2016 Apr;87(4):562-8. doi: 10.1111/cbdd.12688. Epub 2015 Dec 14.

PMID:
26577134
15.

Asthma control uncontrolled.

Jassem E, Niedoszytko M.

Pol Arch Med Wewn. 2015;125(10):711-2. No abstract available.

16.

Effect of beta-blocker therapy on heart rate response in patients with hypertension and newly diagnosed untreated obstructive sleep apnea syndrome.

Wolf J, Drozdowski J, Czechowicz K, Winklewski PJ, Jassem E, Kara T, Somers VK, Narkiewicz K.

Int J Cardiol. 2016 Jan 1;202:67-72. doi: 10.1016/j.ijcard.2015.08.139. Epub 2015 Aug 21.

17.

Asthma prevalence and risk factors analysis in Tricity university students' group.

Romantowski J, Gawinowska M, Cyrny P, Jassem E, Chełmińska M, Niedoszytko M.

Pneumonol Alergol Pol. 2015;83(5):359-64. doi: 10.5603/PiAP.2015.0058.

18.

Analysis of the differences in whole-genome expression related to asthma and obesity.

Gruchała-Niedoszytko M, Niedoszytko M, Sanjabi B, van der Vlies P, Niedoszytko P, Jassem E, Małgorzewicz S.

Pol Arch Med Wewn. 2015;125(10):722-30. Epub 2015 Aug 7.

19.

The statement of the Polish Society of Allergology experts on the treatment of difficult-to-treat asthma.

Bodzenta-Łukaszyk A, Fal AM, Jassem E, Kowalski ML, Kuna P, Kupczyk M.

Pneumonol Alergol Pol. 2015;83(4):324-34. doi: 10.5603/PiAP.2015.0052.

20.

Pulmonary capillary permeability and pulmonary microangiopathy in diabetes mellitus.

Kuziemski K, Pieńkowska J, Słomiński W, Jassem E, Studniarek M.

Diabetes Res Clin Pract. 2015 Jun;108(3):e56-9. doi: 10.1016/j.diabres.2015.02.033. Epub 2015 Mar 6.

PMID:
25836946
21.

Tracheobronchopathia osteochondroplastica—case report and literature review.

Porzezińska M, Janowicz A, Janowiak P, Cynowska B, Sternau A, Pęksa R, Słomiński JM, Jassem E.

Pneumonol Alergol Pol. 2015;83(2):135-9. doi: 10.5603/PiAP.2015.0021. Review.

22.

YKL-40 protein correlates with the phenotype of asthma.

Specjalski K, Chełmińska M, Jassem E.

Lung. 2015 Apr;193(2):189-94. doi: 10.1007/s00408-015-9693-y. Epub 2015 Feb 8.

23.

Nicotine dependence in an isolated population of Kashubians from North Poland: a population survey.

Sieminska A, Jassem E, Kita-Milczarska K.

BMC Public Health. 2015 Feb 4;15:80. doi: 10.1186/s12889-015-1455-5.

24.

Association between genetic variants on chromosome 15q25 locus and several nicotine dependence traits in Polish population: a case-control study.

Buczkowski K, Sieminska A, Linkowska K, Czachowski S, Przybylski G, Jassem E, Grzybowski T.

Biomed Res Int. 2015;2015:350348. doi: 10.1155/2015/350348. Epub 2015 Jan 6.

25.

Risk factors for anaphylaxis in patients with mastocytosis.

Górska A, Niedoszytko M, Lange M, Chełmińska M, Nedoszytko B, Wasąg B, Słomiński JM, Gruchała-Niedoszytko M, Nowicki R, Jassem E.

Pol Arch Med Wewn. 2015;125(1-2):46-53. Epub 2015 Jan 12.

26.

Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?

Lange M, Żawrocki A, Nedoszytko B, Wasąg B, Niedoszytko M, Jassem E, Nowicki R, Żmijewski MA, Biernat W.

Int Arch Allergy Immunol. 2014;165(2):104-10. doi: 10.1159/000368799. Epub 2014 Nov 15.

PMID:
25402852
27.

Opioid receptor bronchial tree: current science.

Krajnik M, Jassem E, Sobanski P.

Curr Opin Support Palliat Care. 2014 Sep;8(3):191-9. doi: 10.1097/SPC.0000000000000072. Review.

PMID:
25010531
28.

[Polish respiratory society guidelines for chronic obstructive pulmonary disease].

Sliwiński P, Górecka D, Jassem E, Pierzchała W.

Pneumonol Alergol Pol. 2014;82(3):227-63. doi: 10.5603/PiAP.2014.0030. Polish. No abstract available.

29.

Factors influencing adherence to treatment in COPD patients and its relationship with disease exacerbations.

Wiśniewski D, Porzezińska M, Gruchała-Niedoszytko M, Niedoszytko M, Słomiński JM, Jassem E.

Pneumonol Alergol Pol. 2014;82(2):96-104. doi: 10.5603/PiAP.2014.0015.

30.

The many faces of tobacco use among women.

Sieminska A, Jassem E.

Med Sci Monit. 2014 Jan 30;20:153-62. doi: 10.12659/MSM.889796. Review.

31.

Molecular profiles of non-small cell lung cancers in cigarette smoking and never-smoking patients.

Szymanowska-Narloch A, Jassem E, Skrzypski M, Muley T, Meister M, Dienemann H, Taron M, Rosell R, Rzepko R, Jarząb M, Marjański T, Pawłowski R, Rzyman W, Jassem J.

Adv Med Sci. 2013;58(2):196-206. doi: 10.2478/ams-2013-0025.

PMID:
24451080
32.

Prognostic value of microRNA expression in operable non-small cell lung cancer patients.

Skrzypski M, Czapiewski P, Goryca K, Jassem E, Wyrwicz L, Pawłowski R, Rzyman W, Biernat W, Jassem J.

Br J Cancer. 2014 Feb 18;110(4):991-1000. doi: 10.1038/bjc.2013.786. Epub 2014 Jan 21.

33.

Transthoracic lung ultrasonography in pulmonary alveolar proteinosis - case report.

Porzezińska M, Buda N, Osowicka M, Kosiak W, Rzepko R, Radzikowska E, Słomiński JM, Jassem E.

Sarcoidosis Vasc Diffuse Lung Dis. 2013 Dec 17;30(4):317-20.

PMID:
24351624
34.

Gene expression analysis in allergology: the prediction of Hymenoptera venom allergy severity and treatment efficacy.

Niedoszytko M, Gruchała-Niedoszytko M, Jassem E.

Clin Transl Allergy. 2013 Oct 27;3(1):35. doi: 10.1186/2045-7022-3-35.

35.

[COPD, lung cancer--a common molecular pathway?].

Jassem E.

Pneumonol Alergol Pol. 2013;81(4):283-4. Polish. No abstract available.

36.

Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.

Skrzypski M, Dziadziuszko R, Jassem E, Szymanowska-Narloch A, Gulida G, Rzepko R, Biernat W, Taron M, Jelitto-Górska M, Marjański T, Rzyman W, Rosell R, Jassem J.

Clin Lung Cancer. 2013 Nov;14(6):666-673.e2. doi: 10.1016/j.cllc.2013.04.010. Epub 2013 Jul 17.

PMID:
23870818
37.

The negative predictive value of typing safe local anesthetics.

Specjalski K, Kita-Milczarska K, Jassem E.

Int Arch Allergy Immunol. 2013;162(1):86-8. doi: 10.1159/000350763. Epub 2013 Jun 27.

PMID:
23816890
38.

The influence of obesity on inflammation and clinical symptoms in asthma.

Gruchała-Niedoszytko M, Małgorzewicz S, Niedoszytko M, Gnacińska M, Jassem E.

Adv Med Sci. 2013;58(1):15-21. doi: 10.2478/v10039-012-0082-y. Review.

PMID:
23729631
39.

Intima-media thickness in patients with obstructive sleep apnea without comorbidities.

Gorzewska A, Specjalski K, Drozdowski J, Kunicka K, Świerblewska E, Bieniaszewski L, Słomiński JM, Jassem E.

Lung. 2013 Aug;191(4):397-404. doi: 10.1007/s00408-013-9471-7. Epub 2013 May 14.

40.

[Coexistence of sarcoidosis with seminoma--a case report].

Kita-Milczarska K, Górska L, Kuziemski K, Sejda A, Jassem E, Biernat W.

Pneumonol Alergol Pol. 2013;81(2):145-8. Polish.

41.

The osteocalcin gene rs1800247 polymorphism in Kashubian population.

Specjalski K, Porzezińska M, Siemińska A, Słomiński JM, Jassem E.

Rheumatol Int. 2013 Dec;33(12):3043-4. doi: 10.1007/s00296-012-2575-1. Epub 2012 Dec 12.

42.

[Recommendations of the Polish Society of Lung Diseases for diagnosis and treatment of chronic obstructive pulmonary disease (COPD)].

Górecka D, Jassem E, Pierzchała W, Sliwiński P; Polskie Towarzystwo Chorób Płuc (PTChP).

Pneumonol Alergol Pol. 2012;80(3):220-54. Polish. No abstract available.

43.

[Chronic obstructive pulmonary disease in women].

Ucińska R, Damps-Konstańska I, Siemińska A, Jassem E.

Pneumonol Alergol Pol. 2012;80(2):140-5. Review. Polish.

44.

[Reccomendation of Polish Respiratory Society for palliative care in chronic lung diseases].

Polskie Towarzystwo Chorób Płuc, Jassem E, Batura-Gabryel H, Cofta S, Doboszyńska A, Farnik M, Górecka D, Korzeniewska-Koseła M, Kozielski J, Krajnik M, Krakowiak P, Słomiński JM, Śliwiński P, Wordliczek J, Szułdrzyński K, Królikowski W, Zajączkowska R, Dobrogowski J, Krzyżanowski D.

Pneumonol Alergol Pol. 2012;80(1):41-64. Polish. No abstract available.

45.

YKL-40 protein is a marker of asthma.

Specjalski K, Jassem E.

J Asthma. 2011 Oct;48(8):767-72. doi: 10.3109/02770903.2011.611955. Epub 2011 Sep 8.

PMID:
21899483
46.

Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis.

Wasag B, Niedoszytko M, Piskorz A, Lange M, Renke J, Jassem E, Biernat W, Debiec-Rychter M, Limon J.

Exp Hematol. 2011 Aug;39(8):859-65.e2. doi: 10.1016/j.exphem.2011.05.009. Epub 2011 May 27.

PMID:
21689725
47.

Changes in gene expression caused by insect venom immunotherapy responsible for the long-term protection of insect venom-allergic patients.

Niedoszytko M, Bruinenberg M, de Monchy J, Weersma RK, Wijmenga C, Jassem E, Elberink JN.

Ann Allergy Asthma Immunol. 2011 Jun;106(6):502-10. doi: 10.1016/j.anai.2011.01.007. Epub 2011 Feb 16.

PMID:
21624750
48.

Diabetic pulmonary microangiopathy - fact or fiction?

Kuziemski K, Specjalski K, Jassem E.

Endokrynol Pol. 2011;62(2):171-6. Review.

49.

Chlamydophila pneumoniae, Mycoplasma pneumoniae infections, and asthma control.

Specjalski K, Jassem E.

Allergy Asthma Proc. 2011 Mar-Apr;32(2):9-17. doi: 10.2500/aap.2011.32.3431.

PMID:
21439159
50.

Gene expression profile, pathways, and transcriptional system regulation in indolent systemic mastocytosis.

Niedoszytko M, Oude Elberink JN, Bruinenberg M, Nedoszytko B, de Monchy JG, te Meerman GJ, Weersma RK, Mulder AB, Jassem E, van Doormaal JJ.

Allergy. 2011 Feb;66(2):229-37. doi: 10.1111/j.1398-9995.2010.02477.x. Epub 2010 Sep 7.

Supplemental Content

Loading ...
Support Center